These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20515608)

  • 1. Stereotactic body radiation therapy for hepatocellular carcinoma.
    Lo SS; Dawson LA; Kim EY; Mayr NA; Wang JZ; Huang Z; Cardenes HR
    Discov Med; 2010 May; 9(48):404-10. PubMed ID: 20515608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
    Méndez Romero A; Wunderink W; Hussain SM; De Pooter JA; Heijmen BJ; Nowak PC; Nuyttens JJ; Brandwijk RP; Verhoef C; Ijzermans JN; Levendag PC
    Acta Oncol; 2006; 45(7):831-7. PubMed ID: 16982547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy for primary hepatocellular carcinoma.
    Andolino DL; Johnson CS; Maluccio M; Kwo P; Tector AJ; Zook J; Johnstone PA; Cardenes HR
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e447-53. PubMed ID: 21645977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
    Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation.
    O'Connor JK; Trotter J; Davis GL; Dempster J; Klintmalm GB; Goldstein RM
    Liver Transpl; 2012 Aug; 18(8):949-54. PubMed ID: 22467602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication.
    Son SH; Choi BO; Ryu MR; Kang YN; Jang JS; Bae SH; Yoon SK; Choi IB; Kang KM; Jang HS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1073-80. PubMed ID: 20207492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
    J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma.
    Seo YS; Kim MS; Yoo SY; Cho CK; Choi CW; Kim JH; Han CJ; Park SC; Lee BH; Kim YH; Lee DH
    J Surg Oncol; 2010 Sep; 102(3):209-14. PubMed ID: 20740576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation.
    Katz AW; Chawla S; Qu Z; Kashyap R; Milano MT; Hezel AF
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):895-900. PubMed ID: 22172906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiation therapy for liver metastases.
    Dawood O; Mahadevan A; Goodman KA
    Eur J Cancer; 2009 Nov; 45(17):2947-59. PubMed ID: 19773153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy: A novel treatment modality for inoperable hepatocellular carcinoma.
    Meng M; Wang H; Zeng X; Zhao L; Yuan Z; Wang P; Hao X
    Drug Discov Ther; 2015 Oct; 9(5):372-9. PubMed ID: 26632546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
    Sanuki N; Takeda A; Oku Y; Mizuno T; Aoki Y; Eriguchi T; Iwabuchi S; Kunieda E
    Acta Oncol; 2014 Mar; 53(3):399-404. PubMed ID: 23962244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy for oligometastases.
    Lo SS; Fakiris AJ; Teh BS; Cardenes HR; Henderson MA; Forquer JA; Papiez L; McGarry RC; Wang JZ; Li K; Mayr NA; Timmerman RD
    Expert Rev Anticancer Ther; 2009 May; 9(5):621-35. PubMed ID: 19445579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
    Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
    Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for solitary hepatocellular carcinoma less than 3 cm in diameter in Child A cirrhosis.
    Poon RT
    Dig Dis; 2007; 25(4):334-40. PubMed ID: 17960069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis.
    Koschny R; Schmidt J; Ganten TM
    Clin Transplant; 2009 Dec; 23 Suppl 21():49-60. PubMed ID: 19930317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors.
    Ibarra RA; Rojas D; Snyder L; Yao M; Fabien J; Milano M; Katz A; Goodman K; Stephans K; El-Gazzaz G; Aucejo F; Miller C; Fung J; Lo S; Machtay M; Sanabria JR
    Acta Oncol; 2012 May; 51(5):575-83. PubMed ID: 22263926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatocellular carcinoma: surgical treatment].
    Gundlach M; Brunken C; Broelsch CE
    Praxis (Bern 1994); 1998 Oct; 87(44):1471-4. PubMed ID: 9847687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformal and stereotactic radiotherapy in hepatocellular carcinoma.
    Scorsetti M; Bignardi M
    Ann Ital Chir; 2008; 79(2):107-10. PubMed ID: 18727272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system.
    Eriguchi T; Takeda A; Sanuki N; Oku Y; Aoki Y; Shigematsu N; Kunieda E
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1006-11. PubMed ID: 23102838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.